-
260 million! The cooperation between two well-known pharmaceutical companies was terminated.
Time of Update: 2020-09-20
Pharmaceutical Co., Ltd. ("Haitron Pharmaceuticals") on September 4th, 2020 . After friendly consultations between the two sides, Sichuan Haisco will grant exclusive license to HC-1119 and the patented products and patented methods of various
-
The bisceptoin pharmaceutical industry passed a consistent evaluation of the mothamine capsule.
Time of Update: 2020-09-20
Company's tymoamine capsule (20mg) was approved for drug registration in December 2011 and is listed as a Class B product in the National Health Insurance Directory.
-
Single anti-undrant Lizhu Group spin-off reagent plate listed to see is 80 billion market mouth?
Time of Update: 2020-09-05
/> first half of this year, the company reported a net profit of 960 million yuan to 1.034 billion yuan, up about 30% to 40% year-on-year. , the gains were mainly due to the sale of antiviral particles, testing reagents and the sale
-
It is not finished to take back the transformation road of the transformation of the pharmaceutical industry introduced by Han Yu to Gaohai.
Time of Update: 2020-09-05
to use the raw materials and channel advantages of local pharmaceutical companies, the patent expired mature drugs in the Chinese market quickly bigger. " Haizheng holds a controlling stake, but in the operation of the Pfizer side more dominant. <br
-
Yuandong Bio 9 major extension service providers wrote off.
Time of Update: 2020-09-05
off, Yuandong Bio 2017 the fifth largest extension service provider Hunan Macheng Pharmaceutical Consulting Services Co., Ltd., the second largest promotional service provider in 2016 Chengdu Tianfa Pharmaceutical Technology Co., Ltd. also carried out
-
Zhao Chunsheng, vice president and deputy general manager of Fish Leap Medical, resigned.
Time of Update: 2020-09-04
former deputy general manager of the company, Vice Chairman and General Manager of Shanghai Medical Devices (Group) Co., Ltd.
-
Hesco will take 2 billion injection varieties to join Forces Hengrui, Zhengda Sunny siege of Merca East.
Time of Update: 2020-09-03
, the current approved domestic enterprises are Hengrui, Zhengda Tianqing and Berry Pharmaceuticals. Figure 1: Hesco's net registration progress for injection acetate capofen Source: CDE Official Website Figure 2: Mercadon Capofen Net Global Sales (units
-
Qilu harvest! Take the lead with 13 heavyweight varieties and 38 over-rated varieties.
Time of Update: 2020-09-03
this year, Qilu pharmaceutical drugs have been approved, the news of evaluation, 2020 has been approved 13 varieties listed; addition, 35 generic (newly registered classifications) were listed for review, mostly anti-tumor and systemic anti-infectant drugs.
-
5 billion antibacterial drug eye dosage form first imitation competition fierce this Wuhan pharmaceutical company new entry.
Time of Update: 2020-09-03
medical institutions) terminal sales of more than 5 billion yuan, of which injections accounted for more than 80%, eye preparations accounted for only 0.02%. , the world's largest ophthalmology company, was a subsidiary of Novarian, completing
-
Two pharmaceutical companies on the same day "shot" siege of 5 billion varieties.
Time of Update: 2020-09-02
is a broad spectrum of triamcinolone antifungal drugs, can inhibit the biosynthesis of the fungus mcprentol and play an antifungal role, candida, trimycinol and other fungi have a bactericidal effect, is the treatment of serious trimycin infection
-
Two billion! Well-known Chinese medicine enterprises treasure island to make chemical drugs.
Time of Update: 2020-09-02
Pharmaceutical Network August 17 - Treasure Island, a well-known Chinese medicine company, said it will raise no more than 2.08 billion yuan for innovative drugs and generic drug research and development platforms and other projects. August 12
-
A billion dollars a year! The transformational medical treatment of listed companies is in a quagmire.
Time of Update: 2020-09-01
Pharmaceutical Network August 18, recently, by the real estate transformation of medical sector listed companies Yihua Health released the 2020 half-year results forecast, financial results show that from real estate to health care transformation
-
Sinopec sells medical devices.
Time of Update: 2020-08-31
popular since the outbreak, low-value supplies in the medical industry demand has increased dramatically, both in terms of quality and price is different from usual. data show that a total of 64 industries in the country's enterprises have
-
Red Day Pharmaceutical Products Blood Must Net Injection included in the New Coronavirus Pneumonia Diagnosis and Treatment Program (Trial 8th Edition)
Time of Update: 2020-08-30
Guide reading: blood must be net injection as one of the company's main products, the exclusive production of Chinese medicine class II new drugs, the national health insurance catalog (class B) varieties.
-
Haizheng Pharmaceuticals has approved the listing of Grello tablets.
Time of Update: 2020-08-30
company for Theguero tablets according to the new category 4 approved by the State Drug Administration for listing, as through the consistency evaluation.
-
Aasheng Pharmaceuticals Announces Interim Results for 2020: The first application for new drug listing has been submitted to continue to advance global strategic cooperation.
Time of Update: 2020-08-30
the reporting period, the company has made great progress in clinical development, external cooperation, patent layout, etc., especially in June this year submitted the company's first new drug listing application (NDA), ushered in a major milestone.
-
The chairman and general manager of Sichuan Fuzheng Pharmaceutical Co., Ltd., a well-known pharmaceutical company, resigned.
Time of Update: 2020-08-30
are: fermented Traditional Chinese medicine (Jianqu, Six Gods, Bile Nanxing, Fried Jianqu, Coking Six Gods, etc.), single-party drink tablets (Snow Bile, Unique Taste, Golden Buckwheat, Yellow Grass, Buckwheat Pollen, Red Sky, etc.), Children's Chinese
-
The company intends to invest in the first new pharmacy.
Time of Update: 2020-08-30
Pharmaceutical Holdings Beijing Professional Pharmacy Co., Ltd." (to industrial and commercial approval), the new company positioning national pharmaceutical shares retail brand flagship store, and as a national pharmaceutical shares retail platform
-
The ophthalmology equipment company completed nearly 100 million yuan round of financing, will accelerate product development.
Time of Update: 2020-08-29
Pharmaceutical Network Enterprise News it is understood that Aikangt Medical Technology Co., Ltd. ("Aiconte") recently completed nearly 100 million yuan A round of financing, and has locked in the A-round financing. the current round
-
GSK and the U.S. mission review strong joint efforts, will work together deep into the pharmaceutical OTC industry.
Time of Update: 2020-08-29
On August 18, U.S. Mission Reviews and GlaxoSmithKly Consumer Health Products China (GSK) announced a comprehensive and in-depth cooperation, and the two sides will work together to deepen the pharmaceutical OTC industry.
